0000899243-22-008583.txt : 20220302 0000899243-22-008583.hdr.sgml : 20220302 20220302160554 ACCESSION NUMBER: 0000899243-22-008583 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Degnan Chris CENTRAL INDEX KEY: 0001741968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 22703403 MAIL ADDRESS: STREET 1: C/O VERRICA PHARMACEUTICALS INC. STREET 2: 10 NORTH HIGH STREET, SUITE 200 CITY: WEST CHESTER STATE: PA ZIP: 19380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-28 0 0001563577 Galera Therapeutics, Inc. GRTX 0001741968 Degnan Chris C/O GALERA THERAPEUTICS, INC. 2 W LIBERTY BLVD #100 MALVERN PA 19355 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 2.24 2022-02-28 4 A 0 135000 0.00 A 2032-02-27 Common Stock 135000 135000 D The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 28, 2022. /s/ Chris Degnan 2022-03-02